 |
|
|
|
|
|
 Title: |
US5894022:
Embolic material for endovascular occlusion of abnormal vasculature and method of using the same
[ Derwent Title ]
|
| Country: |
US United States of America
|
| |
| Inventor: |
Ji, Cheng; Los Angeles, CA
Guglielmi, Guido; Santa Monica, CA
|
| Assignee: |
The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
News, Profiles, Stocks and More about this company
|
| Published / Filed: |
1999-04-13
/ 1997-10-07
|
| Application Number: |
US1997000946608
|
| IPC Code: |
Advanced:
A61K 9/06;
A61K 9/16;
A61K 47/42;
A61L 31/04;
A61L 31/12;
Core:
more...
IPC-7:
A61F 13/00;
A61K 9/14;
|
| ECLA Code: |
A61K9/06; A61K9/16H6H; A61K47/42; A61L31/04F10; A61L31/12D+C08L89/00;
|
| U.S. Class: |
Current:
424/422;
424/484;
Original:
424/422;
424/484;
|
| Field of Search: |
424/422,484,486,499
514/776,938,952,937
|
| Priority Number: |
|
| Abstract: |
The present invention is an endovascular embolic composition. The embolic composition comprises a hydrophilic insoluble matrix having a microscopic mesh-like structure. The voids or intricacies of the matrix enclose droplets of aqueous solution as well as liquid oil. This structure is essentially equivalent to a "gel" structure with the insoluble matrix including both aqueous and oil droplets within its mesh. In creating the matrix a liquid oil base is mixed with an aqueous solution of a matrix base. The matrix base comprises an organic polymer such as a protein like albumin or its equivalent dissolved in an aqueous solution which may contain additional solutes. The matrix base solution is mixed and emulsified with the liquid oil base at a volume ratio ranging between about 1-to-1 and 1-to-5 respectively. To create the embolic composition the matrix base is then precipitated or cross-linked to form a gel with a mesh-like microscopic structure in which insoluble matrix surrounds and entraps both aqueous fluid and liquid oil. Preferably sclerifying agents are included within the composition so that scar tissue will develop to permanently occlude the embolized vasculature.
|
| Attorney, Agent or Firm: |
Dawes, Daniel L. ;
|
| Primary / Asst. Examiners: |
Page, Thurman K.; Howard, Sharon
|
| INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report
|
Nominate this for the Gallery...
